Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

FDA Approves Oral Option for Pediatric Epilepsy

UCB news release; 2017 Nov 6

UCB recently announced that the US Food and Drug Administration (FDA) has approved a label extension for the company's anti-epileptic drug (AED) Vimpat (lacosamide) CV as an oral option for the treatment of partial-onset seizures (POS) in pediatric patients aged ≥4 years. UCB is headquartered in Atlanta, GA, and Brussels, Belgium.

Indications: This new approval provides clinicians with the option to prescribe Vimpat to their pediatric patients either as an oral solution or a convenient tablet, allowing for flexible administration options, an important consideration when treating children.

Dosage/administration: For pediatric patients from 4 years to <17 years, the recommended dosage is based on body weight and is administered orally twice daily. Increased dosage is based on clinical response and tolerability, and no more frequently than once per week is recommended.

Adverse reactions: Adverse reactions in pediatric patients are similar those of adult patients: diplopia, headache, dizziness, and nausea.

Citation:

UCB's VIMPAT® (lacosamide) now approved by FDA to treat partial-onset seizures in pediatric epilepsy patients. [news release]. Atlanta, GA, and Brussels, Belgium: UCB. November 6, 2017. https://www.prnewswire.com/news-releases/ucbs-vimpat-lacosamide-now-approved-by-fda-to-treat-partial-onset-seizures-in-pediatric-epilepsy-patients-300549924.html. Accessed November 9, 2017.

This Week's Must Reads

Tourette Syndrome, Tic Disorders, and Education, JAMA Neurology; ePub 2018 May 29; Pérez-Vigil, et al

RLS with PLMS More Common in Elderly Persons, Sleep; ePub 2018 Jun 1; Doan, Koo, Ogilvie, et al

Predicting Alpha-Synuclein Pathology Pre-Mortem, Parkinsonism Relat Disord; ePub 2018 May 17; Shprecher, et al

Excessive Daytime Sleepiness: Early Feature of DLB , Parkinsonism Relat Disord; 2018 May; Kasanuki, et al

HIV in HD Linked with Earlier Age of Symptom Onset, J Huntingtons Dis; 2018 Jun 1; Schultz, et al

Must Reads in Epilepsy & Seizures

More Severe Seizure Patterns Favor Daytime, Epilepsia; ePub 2018 Apr 23; Goldenholz, et al

Epilepsy, Fertility, and Birth Outcomes Examined , JAMA Neurology; ePub 2018 Apr 30; Pennell, et al

FDA Approves Medtronic’s DBS Therapy for Epilepsy, Medtronic news release; 2018 May 1

Incidence of Periictal Apnea in Epileptic Seizures, Epilepsia; ePub 2018 Jan 16; Lacuey, Zonjy, et al

Epilepsy Seizure Rate and Education Level Linked, Epilepsy Behav; ePub 2017 Dec 24; Kumar, et al